Assignee
XENOTHERA
FR·2 granted patents·1 pending application·0 citations·filing 2015–2021
Top patents by PatentIndex Score
3 records- 0144US12540184B2Association of polyclonal antibodies and anti-PD1 or anti-PDL1 antibodies for the treatment of cancerXENOTHERA·Filed 2020·Granted Feb 3, 2026·0 cites·13 claims
- 0243US2024294612A1Composition of pig polyclonal antibody for its use to treat and/or prevent antibody-dependent macrophage pro-inflammatory cytokine release in a passive anti-infectious immunotherapyXENOTHERA·Filed 2021·Application pending·0 cites
- 0323US11725044B2Method for producing polyclonal antibodies with improved complement-dependent cytotoxicityXENOTHERA·Filed 2015·Granted Aug 15, 2023·0 cites·2 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →